|

SGLT2 inhibitor (Dapagliflozin 10mg) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • The University of Hong Kong1

Indications

  • Dapagliflozin (Forxiga)1
  • Sodium-glucose Cotransporter 2 (SGLT2) Inhibitor1
  • Repaired Tetralogy of Fallot (rTOF)1
  • Pulmonary Regurgitation1
  • Heart Disease1

Other1 trial

Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.